SANTA CLARA, Calif., March 16, 2017 /PRNewswire/ -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing [...]
SANTA CLARA, Calif., Jan 26, 2017 /PRNewswire/ -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), and a global drug discovery and development services company providing translational platforms [...]
SANTA CLARA, Calif., Jan. 12, 2017 /PRNewswire/ --Â Crown Bioscience Inc., a global drug discovery and development services company providing translational platforms to advance cardiovascular and metabolic disease (CVMD) research, expands [...]